News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Hau Bosun
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2020 |
4
| Hau Bosun (Director) has filed a Form 4 on EXICURE, INC.
Txns:
| Granted 21,693 options to buy
@ $2.79, valued at
$60.5k
|
|
01/24/2020 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.
Txns:
| Granted 23,458 options to buy
@ $10.19, valued at
$239k
|
|
08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2019 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.
Txns:
| Granted 14,500 options to buy
@ $16.19, valued at
$234.8k
|
|
06/08/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.
Txns:
| Bought 2,898 shares
@ $34.9399, valued at
$101.3k
|
|
06/05/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.
Txns:
| Bought 7,142 shares
@ $29.1895, valued at
$208.5k
|
|
05/22/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.
Txns:
| Granted 4,499 options to buy
@ $19.71, valued at
$88.7k
|
|
04/26/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.
Txns:
| Granted 9,086 options to buy
@ $8.01, valued at
$72.8k
|
|
03/13/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.
Txns:
| Granted 285 options to buy
@ $19.35, valued at
$5.5k
|
|
|
|